Globus Medical (NASDAQ:GMED) released its earnings data on Tuesday. The company reported $0.24 EPS for the quarter, beating the Thomson Reuters consensus estimate of $0.22 by $0.02, American Banking and Market News reports. The company had revenue of $114.20 million for the quarter, compared to the consensus estimate of $113.59 million. During the same quarter in the prior year, the company posted $0.21 earnings per share. The company’s quarterly revenue was up 8.8% on a year-over-year basis. Globus Medical Inc (NYSE:GMED) shares after opening at $25.21 moved to $25.22 on last trade day and at the end of the day closed at $24.42. Company price to sales ratio in past twelve months was calculated as 5.25 and price to cash ratio as 9.55. Globus Medical Inc (NYSE:GMED) showed a positive weekly performance of 2.78%.
U.S. Silica Holdings (NASDAQ:SLCA) posted its quarterly earnings results on Tuesday. The company reported $0.37 earnings per share for the quarter, beating the consensus estimate of $0.35 by $0.02, Analyst RN reports. The company had revenue of $180.10 million for the quarter, compared to the consensus estimate of $157.81 million. During the same quarter in the previous year, the company posted $0.35 earnings per share. The company’s revenue for the quarter was up 47.3% on a year-over-year basis. U.S. Silica Holdings Inc (NYSE:SLCA) shares advanced 9.05% in last trading session and ended the day on $45.17. SLCA return on equity ratio is recorded as 26.90% and its return on assets is 9.70%. U.S. Silica Holdings Inc (NYSE:SLCA) yearly performance is 125.17%.
Ingredion Inc (NYSE:INGR) reported $0.96 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.26 by $0.70. The company had revenue of $1.36 billion for the quarter, compared to the consensus estimate of $292.14 million. During the same quarter in the previous year, the company posted $1.41 earnings per share. The company’s revenue for the quarter was down 14.3% on a year-over-year basis. Ingredion Inc (NYSE:INGR) shares moved up 5.04% in last trading session and was closed at $70.45, while trading in range of $. 65.25 – 70.62. Ingredion Inc (NYSE:INGR) year to date (YTD) performance is 3.56%.
CRT Capital upgraded shares of Accuride (NYSE:ACW) from a fair value rating to a buy rating in a report released on Tuesday, TheFlyOnTheWall.com reports. CRT Capital currently has $6.00 price objective on the stock, up from their previous price objective of $4.50. Accuride Corporation (NYSE:ACW) weekly performance is 18.74%. On last trading day company shares ended up $5.64. Accuride Corporation (NYSE:ACW) distance from 50-day simple moving average (SMA50) is 23.07%. Analysts mean target price for the company is $4.50.